Improvement of a novel small-diameter tissue-engineered arterial graft with heparin conjugation

Y Matsuzaki, S Miyamoto, H Miyachi, R Iwaki… - The Annals of thoracic …, 2021 - Elsevier
Background Small diameter (< 6 mm), bioabsorbable, arterial, tissue-engineered vascular
grafts (TEVGs) remain limited by thromboembolism. The objective of this study was to test …
被引用次数：27 相关文章

Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation

Y Matsuzaki, S Miyamoto, H Miyachi… - The Annals of …, 2021 - pubmed.ncbi.nlm.nih.gov
Background Small diameter (< 6 mm), bioabsorbable, arterial, tissue-engineered vascular
grafts (TEVGs) remain limited by thromboembolism. The objective of this study was to test …

[引用][C] Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation

Y Matsuzaki, S Miyamoto, H Miyachi, R Iwaki… - The Annals of Thoracic …, 2021 - cir.nii.ac.jp

Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation.

Y Matsuzaki, S Miyamoto, H Miyachi… - The Annals of …, 2020 - europepmc.org
Background Small diameter (< 6 mm), bioabsorbable, arterial, tissue-engineered vascular
grafts (TEVGs) remain limited by thromboembolism. The objective of this study was to test …

Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation

Y Matsuzaki, S Miyamoto… - Annals of …, 2021 - ohiostate.elsevierpure.com
Background: Small diameter (< 6 mm), bioabsorbable, arterial, tissue-engineered vascular
grafts (TEVGs) remain limited by thromboembolism. The objective of this study was to test …

Improvement of a Novel Small-diameter Tissue-engineered Arterial Graft With Heparin Conjugation

Y Matsuzaki, S Miyamoto, H Miyachi… - The Annals of …, 2021 - annalsthoracicsurgery.org
Background Small diameter (< 6 mm), bioabsorbable, arterial, tissue-engineered vascular
grafts (TEVGs) remain limited by thromboembolism. The objective of this study was to test …